Trial Profile
Determination Of FEZ1/LZTS1 Expression As A Predictor Of Response To Taxol.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 23 May 2009 New trial record